Description
Human Leukocyte Antigens (HLA) are found in your blood and are the primary source of immuno-rejection during an organ transplant.  This class of markers is characterized by numerous genetic mutations, many of which directly affect the immune response during an organ transplant.  xMAP technology allows high-resolution genotyping of up to 100 unique alleles within a single sample volume prior to a patient undergoing transplant surgery.  The same xMAP platform can then be used to perform immunoassays that test for an antibody response in the patient post-surgery.  xMAP technology is the clear choice for histocompatibility and transplant immunology labs requiring a high degree of multiplexing and throughput – reducing costs and boosting productivity.

Tests available from:

One Lambda  
Tepnel Lifecodes